Literature DB >> 22412243

Double guiding catheters for complex percutaneous coronary intervention.

Shing-Hsien Chou1, Chia-Pin Lin, Yen-Chen Lin, Chi-Tai Kuo, Ming-Shyan Lin, Chi-Jen Chang.   

Abstract

A large-lumen guiding catheter is often used for complex percutaneous coronary intervention-particularly when a final kissing-balloon or 2-stent technique is required. However, catheter insertion is sometimes restricted by diseased vascular access sites or a tortuous vascular route.We report 2 cases in which a unique double guiding catheter technique was used to create a lumen of sufficient size for complex percutaneous coronary intervention. In each patient, two 6F guiding catheters were used concurrently to engage the ostium of 1 target vessel. In 1 patient, these catheters were used for the delivery of 2 balloons to complete kissing-balloon dilation after single-stent placement. In the other patient, the catheters were used to deliver 2 stents sequentially to their respective target lesions. The stents were then deployed simultaneously as kissing stents, followed by high-pressure kissing-balloon postdilation.

Entities:  

Keywords:  Coronary artery disease/therapy; complex percutaneous coronary intervention; double guiding catheter

Mesh:

Year:  2012        PMID: 22412243      PMCID: PMC3298916     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  7 in total

Review 1.  Contemporary stent treatment of coronary bifurcations.

Authors:  Ioannis Iakovou; Lei Ge; Antonio Colombo
Journal:  J Am Coll Cardiol       Date:  2005-09-28       Impact factor: 24.094

2.  Longest available clinical outcomes after drug-eluting stent implantation for unprotected left main coronary artery disease: the DELFT (Drug Eluting stent for LeFT main) Registry.

Authors:  Emanuele Meliga; Hector Manuel Garcia-Garcia; Marco Valgimigli; Alaide Chieffo; Giuseppe Biondi-Zoccai; Andrew O Maree; Stephen Cook; Lindsay Reardon; Claudio Moretti; Stefano De Servi; Igor F Palacios; Stephen Windecker; Antonio Colombo; Ron van Domburg; Imad Sheiban; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2008-06-10       Impact factor: 24.094

3.  The Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial.

Authors:  Henning Kelbaek; Leif Thuesen; Steffen Helqvist; Lene Kløvgaard; Erik Jørgensen; Samir Aljabbari; Kari Saunamäki; Lars R Krusell; Gunnar V H Jensen; Hans E Bøtker; Jens F Lassen; Henning R Andersen; Per Thayssen; Anders Galløe; Anton van Weert
Journal:  J Am Coll Cardiol       Date:  2005-12-09       Impact factor: 24.094

4.  Comparison of radial versus brachial approaches for diagnostic coronary angiography when the femoral approach is contraindicated.

Authors:  D J Hildick-Smith; P F Ludman; M D Lowe; N G Stephens; A A Harcombe; J T Walsh; D L Stone; L M Shapiro; P M Schofield; M C Petch
Journal:  Am J Cardiol       Date:  1998-03-15       Impact factor: 2.778

5.  A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study.

Authors:  F Kiemeneij; G J Laarman; D Odekerken; T Slagboom; R van der Wieken
Journal:  J Am Coll Cardiol       Date:  1997-05       Impact factor: 24.094

6.  Nine-month outcome of patients treated by percutaneous coronary interventions for bifurcation lesions in the recent era: a report from the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial.

Authors:  Philippe Garot; Thierry Lefèvre; Michael Savage; Yves Louvard; William R Bamlet; James T Willerson; Marie-Claude Morice; David R Holmes
Journal:  J Am Coll Cardiol       Date:  2005-08-16       Impact factor: 24.094

7.  Unprotected left main stenting in the real world: two-year outcomes of the French left main taxus registry.

Authors:  Beatriz Vaquerizo; Thierry Lefèvre; Olivier Darremont; Marc Silvestri; Yves Louvard; Jean Louis Leymarie; Philippe Garot; Helen Routledge; Federico de Marco; Thierry Unterseeh; Marcel Zwahlen; Marie-Claude Morice
Journal:  Circulation       Date:  2009-04-20       Impact factor: 29.690

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.